4d Pharma PLC Block Listing Six Monthly Return (9441Y)
14 Settembre 2020 - 5:30PM
UK Regulatory
TIDMDDDD
RNS Number : 9441Y
4d Pharma PLC
14 September 2020
14 September 2020
4D pharma plc
(the "Company" or "4D")
Block Listing Six Monthly Return
Name of applicant: 4D Pharma plc
Name of scheme: Block Admission for February 2020 warrants
--------------------------------------------------------------
Period of return: From: 10 March 2020 To: 9 September 2020
---------------------- ----------------------- -------- ---------------------------
Number of securities originally admitted at date of 22,000,000 Ordinary Shares of 0.25p each on 10 March 2020
admission:
--------------------------------------------------------------
Balance of unallotted securities under scheme(s) from 22,000,000 Ordinary shares
previous return:
--------------------------------------------------------------
Plus: The amount by which the block scheme(s) has 0 Ordinary shares
been increased since the date of the last
return (if any increase has been applied for):
--------------------------------------------------------------
Less: Number of securities issued/allotted under 0 Ordinary shares
scheme(s) during period:
--------------------------------------------------------------
Equals: Balance under scheme(s) not yet 22,000,000 Ordinary shares
issued/allotted at end of period:
--------------------------------------------------------------
Name of contact: Duncan Peyton
Telephone number of contact: Company Secretary (0113 895 0130)
----------------------------------
Contact Information:
4D
Duncan Peyton, Chief Executive Officer +44 (0)113 895 0130
Investor Relations ir@4dpharmaplc.com
N+1 Singer - Nominated Adviser and Joint Broker +44 (0)20 7496
3000
Aubrey Powell / Justin McKeegan / Iqra Amin (Corporate
Finance)
Tom Salvesen (Corporate Broking)
Bryan Garnier & Co. Limited - Joint Broker +44 (0)20 7332
2500
Dominic Wilson / Phil Walker
Image Box Communications
Neil Hunter / Michelle Boxall +44 (0)20 8943 4685
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRBUGDCIBBDGGS
(END) Dow Jones Newswires
September 14, 2020 11:30 ET (15:30 GMT)
Grafico Azioni 4d Pharma (LSE:DDDD)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni 4d Pharma (LSE:DDDD)
Storico
Da Apr 2023 a Apr 2024
